Pharmacists in Hadley, MA Accepting Medicare

5 Pharmacists found. Showing 1 - 5

Mr. Alexander Stetynski Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 367 Russell St, Hadley, MA 01035 Phone: 413-586-6681    Fax: 413-586-6681

Tracy Loke, ROB Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 367 Russell St., Hadley, MA 01035 Phone: 413-586-6681

Mr. Darren Eli Masse, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 367 Russell St, T-1839, Hadley, MA 01035 Phone: 413-586-6681    Fax: 413-586-6681

Mrs. Harriette C Agu, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 367 Russell St, T-1839, Hadley, MA 01035 Phone: 617-943-0118

Vivian Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 337 Russell St, Hadley, MA 01035 Phone: 413-586-4265

News Archive

ESC believes stress management programmes may reduce recurrent CVD events

Following the results of a study published in the Archives of Internal Medicine showing that cognitive behavioural therapy produces a 41% reduction in fatal and non-fatal first recurrent CVD events, the European Society of Cardiology believes stress management programmes should be made more widely available across Europe for patients with coronary artery disease.

IHW study reveals high prevalence of CVD risk factors in India

The Indian Heart Watch (IHW) study has revealed the truth behind the prevalence, awareness, treatment and control of key risk factors that are driving the country's growing cardiovascular disease (CVD) epidemic, in a first-of-a-kind presentation of data at the World Congress of Cardiology today.

Epidurals and spinal anesthetics safer than previously reported

The largest ever prospective study [1,2] into the major complications [3] of epidurals and spinal anaesthetics published in the British Journal of Anaesthesia today (Monday 12 January 2009) concludes that previous studies have over-estimated the risks of severe complications of these procedures.

Bioxodes completes seed funding round to bring Ir-CPI product into pre-clinical development

Bioxodes SA, a company developing products derived from natural sources, has completed a EUR 2.6 million (USD 3.5 million) first seed funding round with a consortium of business angels and Belgian investment funds. EUR 1.6 million is from the European Regional Development Fund and the Walloon Region in Belgium via the Retech program for Research and Technology. It will be used to bring the company's lead product Ir-CPI into pre-clinical development over the next 18 months.

4 percent of US adults have some form of bipolar disorder

Approximately 4.4 percent of U.S. adults may have some form of bipolar disorder during some point in their lifetime, including about 2.4 percent with a "sub-threshold" condition, according to an article in the May issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

Read more Medical News

› Verified 9 days ago